Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below.
On 27 February 2012, Mr Lowth received shares from the vesting of a previously announced award made in February 2009 under the AstraZeneca Deferred Bonus Plan whereby he has now become beneficially entitled to the shares. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
Name of Director |
Number of shares vested |
Number of shares withheld |
Net number of shares |
Market price on vesting |
Simon Lowth |
9,775 |
5,083 |
4,692 |
2856p |
As a result of these transactions, Mr Lowth has an interest in 243,003 Ordinary Shares, which represent approximately 0.02% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
28 February 2012